Depo-Provera settlement registration deadline: what meningioma claimants should confirm before November 30
Last reviewed: October 11, 2026
For Depo-Provera meningioma claimants, the next important date is
not a trial date. It is a paperwork date.
CMO 14 puts November 30, 2026 on the calendar for settlement
registration. It also says, in a footnote worth reading twice,
that there is "no admission of fault or liability" by the defendants.
That is the awkward middle ground claimants are in right now. There is
a settlement process. There is not a public payout chart. There is a
deadline. And there is no public rule saying every person who ever used
Depo-Provera is automatically in. In other words, do the boring part
now: get the records together.
Our main Depo-Provera lawsuit page covers
the broader allegations in MDL No. 3140. This update is only about the
November 30 registration window and the records we would want to see
in a meningioma review.
The October count is still large
The JPML October 1, 2026 report lists 6,412 pending actions in MDL
No. 3140, with 6,524 total historical actions. The federal cases are in
the Northern District of Florida before Judge M. Casey Rodgers.
The number is still large. It is also moving differently than it was a
few months ago. The public docket now shows a settlement track for
eligible filed claims, plus continued litigation for claims that do not
resolve through that program.
CMO 12 dates the Master Settlement Agreement to July 21, 2026. The same order says the parties estimated that roughly
80% of MDL plaintiffs would be eligible. Helpful, yes, but not a promise
to any one person. The eligibility rules are in the private agreement,
and CMO 12 says the settlement is not subject to a court fairness
review because the MDL is not a class action.
Records to pull before the deadline
If this were our file, we would start with proof of use. Not a memory of
"I was on the shot," but records showing dates and products. One missing
clinic ledger can turn a strong-sounding story into a hard review,
especially if the shots happened years ago.
Check these first:
- OB/GYN offices, family planning clinics, county health departments,
college clinics, and primary care offices; - pharmacy benefit records and insurance explanation-of-benefits
records; - old patient portals, appointment histories, billing ledgers, and
injection logs; - MRI or CT reports identifying a meningioma;
- neurology, neurosurgery, radiation oncology, surgery notes, pathology,
and later follow-up records.
The details can matter. First shot. Last shot. Product name. Date of the
first scan. Date of diagnosis. Date of surgery or radiation, if there
was surgery or radiation.
If you already have counsel, ask whether your registration file is
complete. If you do not have counsel, do not assume this settlement
registration deadline works the same way for you as it does for someone
already filed in the MDL. State filing deadlines and individual facts
can change the answer.
Why the science still shows up in claim review
The settlement process does not erase the medical questions.
The 2024 BMJ study from France reported an association between
prolonged use of injectable medroxyprogesterone acetate and
intracranial meningioma requiring surgery. A later U.S. cohort study,
indexed on PubMed and published in JAMA Neurology, reported a higher
relative risk of later meningioma diagnosis among depot
medroxyprogesterone acetate users compared with controls. In that U.S.
study, the signal was clearest for longer exposure and for patients who
started after age 31.
Those studies do not prove what caused one person's tumor. They do
explain why claim reviews keep coming back to duration of use, timing,
imaging, and diagnosis records.
The FDA label now has a meningioma warning for Depo-Provera. In plain
English, it tells prescribers to watch for meningioma symptoms and to
stop Depo-Provera CI if a meningioma is diagnosed. Do not stop or
switch contraception because of this article. Bring that question to a
clinician who knows your medical history.
Things we would not rely on
We would not rely on rumored payout charts. Public court orders confirm
a settlement process, but they do not publish final individual payment
amounts.
We would not wait until the last week to request old records. Some
clinics move slowly. Some older files are archived. Some patient portals
show only recent visits.
We also would not treat this as a class action. MDL coordination does
not make every claim the same. Each person still has her own exposure
history, diagnosis history, deadline questions, and injury evidence.
Our earlier article on Depo-Provera settlement administration
orders
explains the court-appointed settlement roles. Our article on
Depo-Provera settlement talks and
records
explains why records matter more than online rumors.
FAQ
Does the November 30 date apply to every claim?
No. CMO 14 identifies November 30, 2026 as the settlement registration
deadline the court understands for the settlement program. Filing
deadlines can still vary by state and by individual facts.
Did Pfizer admit Depo-Provera caused meningiomas?
No. CMO 14 says there is no admission of fault or liability by the
defendants in connection with the settlement.
If the shot records are hard to find
Start with the office that gave the injections. Then check insurance,
pharmacy benefit files, patient portals, billing records, and old
appointment histories. A review usually needs documents, not just
memory.
Sources
Mass Tort America provides legal information and case-review
connections. This page is attorney advertising and is for general
information only. It is not medical advice and does not promise
compensation or a legal outcome.
Robert B. Baker, Esq., B.C.S. — Board-Certified Civil Trial Lawyer. 30+ years of trial experience, more than $400 million recovered for clients. About Robert Baker →